These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes. Divine MR; Katiyar P; Kohlhofer U; Quintanilla-Martinez L; Pichler BJ; Disselhorst JA J Nucl Med; 2016 Mar; 57(3):473-9. PubMed ID: 26659350 [TBL] [Abstract][Full Text] [Related]
4. Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation. Boussouar S; Itti E; Lin SJ; Decaens T; Evangelista E; Chiaradia M; Chalaye J; Baranes L; Calderaro J; Laurent A; Pigneur F; Duvoux C; Azoulay D; Costentin C; Rahmouni A; Luciani A Cancer Imaging; 2016 Feb; 16():4. PubMed ID: 26883745 [TBL] [Abstract][Full Text] [Related]
5. Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from Chung YH; Tsai CK; Yu CF; Wang WL; Yang CL; Hong JH; Yen TC; Chen FH; Lin G Molecules; 2021 Apr; 26(9):. PubMed ID: 33925109 [TBL] [Abstract][Full Text] [Related]
6. Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging. Schelhaas S; Wachsmuth L; Viel T; Honess DJ; Heinzmann K; Smith DM; Hermann S; Wagner S; Kuhlmann MT; Müller-Tidow C; Kopka K; Schober O; Schäfers M; Schneider R; Aboagye EO; Griffiths J; Faber C; Jacobs AH J Nucl Med; 2014 Jun; 55(6):983-8. PubMed ID: 24777288 [TBL] [Abstract][Full Text] [Related]
7. PET Imaging of Hepatocellular Carcinomas: Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ida Y; Tamai H; Shingaki N; Shimizu R; Maeshima S; Maekita T; Iguchi M; Terada M; Kitano M Cancer Imaging; 2020 Oct; 20(1):74. PubMed ID: 33076990 [TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549 [TBL] [Abstract][Full Text] [Related]
10. Utility of Early Posttreatment PET/CT Evaluation Using FDG or Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448 [No Abstract] [Full Text] [Related]
11. Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient. Kong E; Chun KA; Cho IH PLoS One; 2017; 12(7):e0180184. PubMed ID: 28672016 [TBL] [Abstract][Full Text] [Related]
12. HRD1 attenuates the high uptake of [ Li AM; Lin XW; Shen JT; Li M; Zheng QH; Zhou ZY; Shi M Nucl Med Biol; 2021; 96-97():27-34. PubMed ID: 33725499 [TBL] [Abstract][Full Text] [Related]
13. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921 [TBL] [Abstract][Full Text] [Related]
14. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience. Hectors SJ; Wagner M; Besa C; Huang W; Taouli B Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045 [TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Lee M; Jeon JY; Neugent ML; Kim JW; Yun M Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy. Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365 [TBL] [Abstract][Full Text] [Related]
17. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer. Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336 [TBL] [Abstract][Full Text] [Related]
18. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845 [TBL] [Abstract][Full Text] [Related]
19. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734 [TBL] [Abstract][Full Text] [Related]
20. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. Dirix P; Vandecaveye V; De Keyzer F; Stroobants S; Hermans R; Nuyts S J Nucl Med; 2009 Jul; 50(7):1020-7. PubMed ID: 19525447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]